Lipoic Acid Pharmacokinetics at Baseline and 1 year in Secondary Progressive MS

Neurol Neuroimmunol Neuroinflamm. 2017 Jun 28;4(5):e380. doi: 10.1212/NXI.0000000000000380. eCollection 2017 Sep.

Authors

Frank Bittner¹, Charles Murchison¹, Dennis Koop¹, Dennis Bourdette¹, Rebecca Spain¹

Affiliation

¹ VA Portland Health Care System (F.B., C.M., D.B., R.S.), OR; and Oregon Health & Science University (F.B., C.M., D.K., D.B., R.S.), Portland.

No abstract available

Grants and funding

UL1 TR002369/TR/NCATS NIH HHS/United States